Abstract: An electronic device is provided. The electronic device includes a communication circuit, a memory configured to store a partial ledger including a part of a full ledger for a blockchain network or the full ledger, and a processor. The processor is configured to generate a first transaction using a smart contract including shared data of the electronic device and information on an external user to receive the shared data, request to transmit the first transaction to the blockchain network, verify the first transaction using a node creating at least one block corresponding to each of at least one transaction, transmit the first transaction to the blockchain network, create a first block corresponding to the first transaction, verify a second transaction based on receiving a second transaction, execute the smart contract, and to create a second block corresponding to the second transaction.

Abstract: The disclosure relates to a method for processing a communication path in a portable communication device, which includes: identifying whether at least some of a plurality of active elements included in a communication circuit disposed between an antenna and a communication processor are in an abnormal state and, based on an abnormal state of a first active element supporting delivery of a signal of a first frequency band among the plurality of active elements being detected, controlling the portable communication device to deliver the signal of the first frequency band based on a second active element different form the first active element among the plurality of active element, and a portable communication device supporting the same.

Abstract: An electronic device is provided. The electronic device includes a first housing, a second housing slidably disposed with the first housing, a rollable display having a display area reduced or expanded based on slide-in or slide-out of the second housing, a pipeline having a first opening disposed on one side of the second housing for an inflow of external air flows, having a second opening disposed in a direction toward the first housing, and extending from the first opening in a direction toward the second opening, an air sensor disposed at least in part inside the pipeline, and an opening and closing member disposed to be fixed to the first housing and opening or closing the second opening of the pipeline based on slide-in or slide-out of the second housing.

Abstract: The present invention relates to novel piperazine derivatives or pharmaceutically acceptable salts thereof, a process for preparing the same, and in particular, a high binding for Serotonin 1A(5-hydroxytryptamine; 5-HT1A) receptor, a pharmaceutical composition for treatment and/or prevention of depression and anxiety including an effective amount of the piperazine compound, and a method of treating depression, anxiety and other conditions related to 5-HT1A receptor in a mammal.

Abstract: The present invention relates to novel piperazine derivatives or pharmaceutically acceptable salts thereof, a process for preparing the same, and in particular, a high binding for Serotonin 1A(5-hydroxytryptamine; 5-HT1A) receptor, a pharmaceutical composition for treatment and/or prevention of depression and anxiety including an effective amount of the piperazine compound, and a method of treating depression, anxiety and other conditions related to 5-HT1A receptor in a mammal.

Abstract: The present invention relates to a novel piperazine derivative or pharmaceutically acceptable salt thereof, a process for preparing the same, a pharmaceutical composition for treating central nervous system diseases comprising an effective amount of the piperazine compound and a method of treating central nervous system (CNS) disorder such as psychosis in a mammal.

Abstract: The present invention relates to novel piperazine derivatives or pharmaceutically acceptable salts thereof, a process for preparing the same, and in particular, a high binding for Serotonin 1A(5-hydroxytryptamine; 5-HT1A) receptor, a pharmaceutical composition for treatment and/or prevention of depression and anxiety including an effective amount of the piperazine compound, and a method of treating depression, anxiety and other conditions related to 5-HT1A receptor in a mammal

Abstract: The present invention relates to novel piperazine derivatives or pharmaceutically acceptable salts thereof, a process for preparing the same, and in particular, a high binding for Serotonin 1A(5-hydroxytryptamine; 5-HT1A) receptor, a pharmaceutical composition for treatment and/or prevention of depression and anxiety including an effective amount of the piperazine compound, and a method of treating depression, anxiety and other conditions related to 5-HT1A receptor in a mammal.

Abstract: The present invention relates to a novel piperazine derivative or pharmaceutically acceptable salt thereof, a process for preparing the same, a pharmaceutical composition for treating central nervous system diseases comprising an effective amount of the piperazine compound and a method of treating central nervous system (CNS) disorder such as psychosis in a mammal.